Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BCAL Diagnostics Limited ( (AU:BDX) ) just unveiled an announcement.
BCAL Diagnostics Limited has announced a change in the interests of its director, Jayne Shaw, in the company’s securities. The change involves an acquisition of 96,722 ordinary shares through an on-market purchase, bringing her total holdings to various amounts across different accounts. This update reflects the director’s increased stake in the company, potentially signaling confidence in the company’s future prospects.
More about BCAL Diagnostics Limited
Average Trading Volume: 440,858
Technical Sentiment Signal: Buy
Current Market Cap: A$34.21M
For a thorough assessment of BDX stock, go to TipRanks’ Stock Analysis page.